HB Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
15,185
+7,892
+108% +$671K 0.01% 668
2026
Q1
$628K Buy
7,293
+3,332
+84% +$299K ﹤0.01% 864
2025
Q4
$346K Buy
+3,961
New +$301K ﹤0.01% 1068
2025
Q2
– Sell
-3,804
Closed -$278K – 1215
2025
Q1
$278K Buy
3,804
+170
+5% +$14K ﹤0.01% 1004
2024
Q4
$301K Buy
+3,634
New +$287K ﹤0.01% 814

Other funds holding GMED

HB Wealth Management's GMED Position: Q2 2026 in Review

HB Wealth Management increased its Globus Medical (GMED) stake by 108% in Q2 2026, buying an estimated $671K and bringing the position to 15,185 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #668.

HB Wealth Management first reported a position in GMED in Q4 2024 and has held it in 5 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • HB Wealth Management held 15,185 shares of Globus Medical worth $1.2M as of Q2 2026.
  • HB Wealth Management bought 7,892 Globus Medical shares in Q2 2026, an estimated $671K.
  • Globus Medical made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #668 holding.
  • HB Wealth Management first reported a position in Globus Medical in Q4 2024 and has held it in 5 quarters since.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.